BPM
DGX icon

Bowling Portfolio Management’s Quest Diagnostics DGX Stock Holding History

Bowling Portfolio Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,095
Closed -$1.55M – 211
2021
Q1 		$1.55M Buy
+12,095
New +$1.49M 0.37% 107
2017
Q4 		– Sell
-30,143
Closed -$2.82M – 362
2017
Q3 		$2.82M Sell
30,143
-5,828
-16% -$619K 0.42% 72
2017
Q2 		$4M Sell
35,971
-5,375
-13% -$568K 0.59% 48
2017
Q1 		$4.06M Buy
+41,346
New +$3.94M 0.67% 46

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Bowling Portfolio Management's DGX Position: Q2 2021 in Review

Bowling Portfolio Management sold out of Quest Diagnostics (DGX) in Q2 2021, closing a stake of 12,095 shares — an estimated $1.55M sold.

Bowling Portfolio Management first reported a position in DGX in Q1 2017 and held it in 4 quarters. The position peaked at $4.06M in Q1 2017. 814 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

  • Bowling Portfolio Management reported no remaining Quest Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Bowling Portfolio Management sold 12,095 Quest Diagnostics shares in Q2 2021, an estimated $1.55M.
  • Bowling Portfolio Management first reported a position in Quest Diagnostics in Q1 2017 and held it in 4 quarters.
  • Bowling Portfolio Management's Quest Diagnostics position peaked at $4.06M in Q1 2017.
  • 814 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on Bowling Portfolio Management's 13F filing for Q2 2021, filed 30 Jul 2021.